Blueprint Investment Partners LLC Novartis Ag Transaction History

Blueprint Investment Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$80.03 - $92.81 $30,091 - $34,896	376 Added 13.59%	3,142 $289,000
Q4 2022 Feb 14, 2023	BUY	$75.55 - $92.52 $208,971 - $255,910	2,766 New	2,766 $250,000
Q2 2022 Aug 09, 2022	BUY	$80.52 - $93.75 $311,209 - $362,343	3,865 New	3,865 $327,000
Q4 2021 Feb 15, 2022	SELL	$79.7 - $88.13 $272,733 - $301,580	-3,422 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$81.78 - $95.14 $279,851 - $325,569	3,422 New	3,422 $280,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Blueprint Investment Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Blueprint Investment Partners LLC with notifications on news.